American Green, Inc. (OTCPK: ERBB)
Health Care · Pharmaceuticals · US
$0.00
-33.33% today · -33.3% 1Y
American Green, Inc. (OTCPK: ERBB) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $868.45K and employs 12 people.
Over the last twelve months the share price has lost 33.3%, trading between 0.00 and 0.00.
Tweenvest scores American Green, Inc. across four factors: value 75/100. Its strongest factor is value.
ERBB price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $868.45K
- Revenue (TTM)
- $48.63K
- P/E
- —
- EPS
- -0.15
- Dividend yield
- —
- Beta (5Y)
- 0.38
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 4.34B
- Employees
- 12
- Next earnings
- —
About American Green, Inc.
American Green, Inc. operates as a technology company in the medical cannabis industry in the United States. It develops retail, brand, and commercial cultivating solutions in partnership with licensed retail medical marijuana dispensaries operated under the American Green brand name. The company operates a consumer operated marijuana vending machine for automated, age-verifying dispensing of cannabis-based medicines. It also offers Jurassic Water for cannabis plants; truth lighting, a LED lighting solution; and OG tea nutrients, a specialty fertilizer product, as well as hemp creams and hemp lip balms through e-commerce. It has collaboration agreement with Endexx Corporation to develop the Access Control Identification and Verification Vending Platform. The company was formerly known as Tranzbyte Corporation and changed its name to American Green, Inc. in May 2014. American Green, Inc. was incorporated in 1998 and is headquartered in Sheridan, Wyoming.
- ISIN
- US02640N2009
- Founded
- 1998
- Listed since
- Aug 27, 1996
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,246.93 | -0.67% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.04 | +1.04% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $150.66 | -1.24% |
| Roche Holding AGSWX: ROP | $368.80B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $27.97 | -0.36% |
Figures last refreshed Aug 18, 2026.